Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting

被引：1

作者：

Fougerousse, A. -C. ^{[1
]}

Maccari, F. ^{[2
]}

Beauchet, A. ^{[3
,4
]}

Parier, J. ^{[2
]}

Boulard, C. ^{[5
]}

Becherel, P. -A. ^{[6
]}

Quiles-Tsimaratos, N. ^{[7
]}

Le Guyadec, T. ^{[8
]}

Thomas-Beaulieu, D. ^{[9
]}

Halioua, B. ^{[10
]}

Begon, E. ^{[11
]}

Bastien, M. ^{[12
]}

Perrot, J. -L. ^{[13
]}

Pallure, V. ^{[14
]}

Bilan, P. ^{[15
]}

Steff, M. ^{[15
]}

Pfister, P. ^{[10
]}

Vermersch-Langlin, A. ^{[16
]}

Boye, T. ^{[17
]}

Mery-Bossard, L. ^{[18
]}

Maillard, H. ^{[19
]}

Kemula, M. ^{[10
]}

Girard, C. ^{[20
]}

Poiraud, C. ^{[21
]}

Monfort, J. -B. ^{[22
]}

Kupfer-Bessaguet, I. ^{[23
]}

Perrussel, M. ^{[24
]}

Lons-Danic, D. ^{[25
]}

Sultan, N. ^{[26
]}

Lorier, E. ^{[10
]}

Zeitoun, M. ^{[27
]}

Wagner, L. ^{[10
]}

Gabison, G. ^{[28
]}

Mahe, E. ^{[29
]}

机构：

[1] Hop Instruct Armees Begin, Dept Dermatol, St Mande, France

[2] Private Off, La Varenne St Hilaire, France

[3] Univ Paris Saclay, CHU Ambroise Pare, AP HP, Dept Publ Hlth, Boulogne, France

[4] Univ Paris Saclay, UVSQ, Boulogne, France

[5] Hop Havre, Dept Dermatol, Montivilliers, France

[6] Hop Prive Antony, Dept Dermatol, Antony, France

[7] Hop St Joseph, Dept Dermatol, Marseille, France

[8] Hop Instruct Armees Percy, Dept Dermatol, Clamart, France

[9] Ctr Hosp Intercommunal Poissy St Germain Laye, Dept Dermatol, Poissy, France

[10] Private Off, Paris, France

[11] Hop Rene Dubos, Dept Dermatol, Pontoise, France

[12] Private Off, Joinville Le Pont, France

[13] CHU St Etienne, Dept Dermatol, St Etienne, France

[14] Ctr Hosp, Dept Dermatol, Perpignan, France

[15] Ctr Hosp Robert Ballanger, Dept Dermatol, Aulnay Sous Bois, France

[16] Ctr Hosp, Dept Dermatol, Valenciennes, France

[17] Hop Instruct Armees St Anne, Dept Dermatol, Toulon, France

[18] Ctr Hosp Francois Quesnay, Dept Dermatol, Mantes La Jolie, France

[19] Ctr Hosp, Dept Dermatol, Le Mans, France

[20] CHU St Eloi, Dept Dermatol, Montpellier, France

[21] Ctr Hosp, Dept Dermatol, La Roche Sur Yon, France

[22] CHU Tenon, Dept Dermatol, Paris, France

[23] Ctr Hosp, Dept Dermatol, Niort, France

[24] Private Off, Auray, France

[25] Hop St Joseph, Dept Dermatol, Paris, France

[26] Ctr Hosp Gabriel Martin, Dept Dermatol, St Paul, France

[27] Private Off, Antony, France

[28] Private Off, St Maurice, France

[29] Hop Victor Dupouy, Dept Dermatol, Argenteuil, France

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷 / 12期

关键词：

EXPERIENCE; SURVIVAL;

D O I：

10.1111/jdv.15804

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：E476 / E478

页数：3

共 50 条

[21] Real-world experiences of apremilast in clinics for Japanese patients with psoriasis
Saruwatari, Hiroshi
JOURNAL OF DERMATOLOGY, 2019, 46 (12): : 1166 - 1169
[22] Real-world switch patterns and healthcare costs in biologic-naive psoriasis patients initiating apremilast or biologics
Wu, Jashin J.
Pelletier, Corey
Ung, Brian
Tian, Marc
Khilfeh, Ibrahim
Curtis, Jeffrey R.
JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (11) : 767 - 779
[23] Methotrexate in a Real-World Psoriasis Treatment: Is It Really a Dangerous Medication for All?
Kim, Bo Ri
Ohn, Jungyoon
Choi, Chong Won
Youn, Sang Woong
ANNALS OF DERMATOLOGY, 2017, 29 (03) : 346 - 348
[24] Real-world, single-centre experience of apremilast for the treatment of moderate to severe psoriasis
Wong, T. H.
Sinclair, S.
Smith, B.
Fraser, C.
Morton, C. A.
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2017, 42 (06) : 675 - 676
[25] Clinical efficacy and safety of secukinumab for psoriasis in a real-world setting in Turkey
Yildirim, Fatma Elif
Hapa, Fatma Asli
JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1531 - 1537
[26] CLINICAL CHARACTERISTICS OF GENERALIZED PUSTULAR PSORIASIS FLARES IN THE REAL-WORLD SETTING
Lavasani, L.
Rasouliyan, L.
Noe, M.
Rhoads, J.
VALUE IN HEALTH, 2023, 26 (12) : S249 - S249
[27] Ixekizumab treatment in patients with moderate-to-severe plaque psoriasis in a real-world clinical setting
Ogut, Neslihan Demirel
Yildirim, Sema Koc
Erbagci, Ece
Hapa, Fatma Asli
JOURNAL OF COSMETIC DERMATOLOGY, 2022, 21 (11) : 6215 - 6224
[28] Trends in the use of biologics for treatment of plaque psoriasis in the real-world setting
Rasouliyan, Lawrence
Althoff, Amanda G.
Kumar, Vikas
Zema, Carla
Long, Stacey
Rao, Mitesh B.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 485 - 485
[29] REAL-WORLD COSTS IN BIOLOGIC-NAIVE PSORIASIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE
Kaplan, D.
Ung, B.
Pelletier, C.
Udeze, C.
Tian, M.
VALUE IN HEALTH, 2019, 22 : S888 - S888
[30] EGFR Testing Practices, Treatment Choice and Clinical Outcomes in Advanced NSCLC in a Real-World Setting
Subramanian, J.
Gregg, J.
Berktas, M.
Jiang, Z.
Li, J.
Taylor, A.
Leighl, N.
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S438 - S439

← 1 2 3 4 5 →